NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

nCino Beats on Q2 but Shares Drop as Guidance Falls Short of Growth Expectations

nCino beat Q2 on revenue, margins and cash flow, but modest full-year guidance and in-line Q3 outlook lack the growth acceleration expected.

nCino Beats on Q2 but Shares Drop as Guidance Falls Short of Growth Expectations
Credit: nCino
Already have an account? Sign in.
08/25/2026 · 5:27 PM
NCNO
/ Don’t stop at just one post.

Related↓

nCino Stock Surges After Profits More Than Double and Full-Year Guidance Raised
05/28/2026 · 6:41 AM

nCino Stock Surges After Profits More Than Double and Full-Year Guidance Raised

nCino beat expectations, raised outlook, and saw strong growth, sending its stock up as investors regained confidence in its AI banking platform.

/ Subscriber only
/ Read more

Feed↓

Intuit Beats on 2026 Results but Misses 2027 Guidance as It Bets on Customer Growth
08/25/2026 · 5:04 PM

Intuit Beats on 2026 Results but Misses 2027 Guidance as It Bets on Customer Growth

Intuit will report Mailchimp as a standalone segment in FY2027, forecasting flat to -1% revenue growth from weaker marketing sales that weighed on its soft full-year outlook.

/ Subscriber only
Strong Q2 Results Overshadowed by Weaker Near-Term Profit Guidance at Zoom
08/25/2026 · 4:45 PM

Strong Q2 Results Overshadowed by Weaker Near-Term Profit Guidance at Zoom

Zoom beats Q2 estimates on revenue and EPS but issues softer Q3 guidance for non-GAAP operating income and EPS, while modestly raising full-year EPS outlook.

/ Subscriber only
Phase 2 Data Support TL1A Inhibition in RA, but Spyre Opts Against Monotherapy Priority
Featured/ 08/25/2026 · 4:27 PM

Phase 2 Data Support TL1A Inhibition in RA, but Spyre Opts Against Monotherapy Priority

Spyre’s RA drug showed benefits and good safety, but results weren’t strong enough to justify developing it as a stand-alone treatment.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe